Channing Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $9.22M | Sell |
|
|||||
|
2024
Q3 | $9.97M | Buy |
|
|||||
|
2024
Q2 | $10.4M | Sell |
|
|||||
|
2024
Q1 | $13.8M | Hold |
|
|||||
|
2023
Q4 | $12M | Buy |
|
|||||
|
2023
Q3 | $9.71M | Buy |
|
|||||
|
2023
Q2 | $7.96M | Sell |
|
|||||
|
2023
Q1 | $9.94M | Sell |
|
|||||
|
2022
Q4 | $13.4M | Sell |
|
|||||
|
2022
Q3 | $12.2M | Buy |
|
|||||
|
2022
Q2 | $6.42M | Sell |
|
|||||
|
2022
Q1 | $13.8M | Buy |
|
|||||
|
2021
Q4 | $12.1M | Buy |
|
|||||
|
2021
Q3 | $10.8M | Sell |
|
|||||
|
2021
Q2 | $12.8M | Sell |
|
|||||
|
2021
Q1 | $12M | Buy |
|
|||||
|
2020
Q4 | $8.75M | Sell |
|
|||||
|
2020
Q3 | $8.73M | Sell |
|
|||||
|
2020
Q2 | $8.12M | Sell |
|
|||||
|
2020
Q1 | $34.9M | Sell |
|
|||||
|
2019
Q4 | $54.6M | Sell |
|
|||||
|
2019
Q3 | $49.3M | Sell |
|
|||||
|
2019
Q2 | $54.7M | Sell |
|
|||||
|
2019
Q1 | $67.3M | Sell |
|
|||||
|
2018
Q4 | $60M | Sell |
|
|||||
|
2018
Q3 | $89.7M | Sell |
|
|||||
|
2018
Q2 | $77.3M | Sell |
|
|||||
|
2018
Q1 | $74.9M | Buy |
|
|||||
|
2017
Q4 | $63M | Buy |
|
|||||
|
2017
Q3 | $52.6M | Sell |
|
|||||
|
2017
Q2 | $70.5M | Sell |
|
|||||
|
2017
Q1 | $74.3M | Sell |
|
|||||
|
2016
Q4 | $64M | Buy |
|
|||||
|
2016
Q3 | $57.3M | Buy |
|
|||||
|
2016
Q2 | $56.5M | Sell |
|
|||||
|
2016
Q1 | $52.5M | Buy |
|
|||||
|
2015
Q4 | $55.3M | Buy |
|
|||||
|
2015
Q3 | $36.4M | Buy |
|
|||||
|
2015
Q2 | $38.4M | Buy |
|
|||||
|
2015
Q1 | $42.8M | Buy |
|
|||||
|
2014
Q4 | $32.5M | Sell |
|
|||||
|
2014
Q3 | $32.3M | Buy |
|
|||||
|
2014
Q2 | $26.2M | Buy |
|
|||||
|
2014
Q1 | $22.8M | Sell |
|
|||||
|
2013
Q4 | $25.4M | Buy |
|
|||||
|
2013
Q3 | $20.8M | Buy |
|
|||||
|
2013
Q2 | $15M | Buy |
|